Lallemand Pharma

News details


Business Continuity related to Covid-19 situation

Mar 19, 2020

Dear Partners, dear Colleagues, dear All,

It is the responsibility of all the players in the health, food and pharmaceutical sector to work together to provide an adapted answer to support our partners, colleagues, researchers, scientific community, doctors, nurses and globally all active people who are part of this valuable chain to ensure the Health and protection of people worldwide.

Thus, in this terrible moment unseen in the entire century, we would like to inform you of the actions taken and revised on a regular basis by Lallemand Pharma to face the COVID-19 pandemic crisis.

We follow carefully the recommendations of the governments and apply strictly the hygienic and safety procedures.

We ensure a business continuity at each critical stage of the valuable chain to continue bringing you, our utmost quality drugs, services and supports to all players.

Find out our full Business Continuity Plan communication by connecting to your account